Print

3BNC117-LS

NCT03254277

Trial Details:

I Ongoing
3BNC117-LS
HIV-uninfected and HIV-infected individuals.
RandD/trials/Lists/ClinicalTrialsList
10/1/2019
3BNC117-LS antibody with aa mutations, M428L and N434S, in the Fc domain       
?HIV-uninfected one infusion of 3BNC117-LS dosed at 3 mg/kg HIV-uninfected one infusion of 3BNC117-LS dosed at 10 mg/kg. HIV-uninfected one infusion of 3BNC117-LS dosed at 30 mg/kg. HIV-infected on ART one infusion of 3BNC117-LS dosed at 10 mg/kg. HIV-inf